Scotland business

ProStrakan completes acquisition of Archimedes Pharma

Sancuso patch
ProStrakan's products include an anti-nausea skin patch for cancer patients

Borders-based drugs firm ProStrakan has announced that it has completed its acquisition of cancer pain specialist Archimedes Pharma.

The Galashiels firm, which is a subsidiary of Japanese pharmaceutical company Kyowa Hakko Kirin (KHK), bought Archimedes for £230m in cash.

The deal was concluded after being cleared by regulators in Germany.

Archimedes' main product is a fentanyl nasal spray, used in managing cancer pain in patients.

ProStrakan, whose products include an anti-nausea skin patch for cancer patients, said the transaction would expand its businesses in four of the largest European markets - the UK, France, Germany and Spain.

Chief executive Tom Stratford said: "Completing this acquisition is an important step in our strategy to expand our presence in Europe and I am confident that together we can further accelerate the success of our European operations."

More on this story

Related Internet links

The BBC is not responsible for the content of external Internet sites